Cite
HARVARD Citation
van Vollenhoven, R. et al. (2013). Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients. Annals of the rheumatic diseases. 72 (9), pp. 1496-1502. [Online].